SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097118
Filing Date
2024-11-13
Accepted
2024-11-13 07:05:40
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220114-10q_unicycive.htm   iXBRL 10-Q 983481
2 CERTIFICATE OF CORRECTION TO SERIES B PREFERRED CERTIFICATE OF DESIGNATION FILED ea022011401ex3-1_unicycive.htm EX-3.1 6128
3 CERTIFICATION ea022011401ex31-1_unicycive.htm EX-31.1 11082
4 CERTIFICATION ea022011401ex31-2_unicycive.htm EX-31.2 11060
5 CERTIFICATION ea022011401ex32-1_unicycive.htm EX-32.1 4047
6 CERTIFICATION ea022011401ex32-2_unicycive.htm EX-32.2 4029
  Complete submission text file 0001213900-24-097118.txt   6549146

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE uncy-20240930.xsd EX-101.SCH 66612
8 XBRL CALCULATION FILE uncy-20240930_cal.xml EX-101.CAL 35146
9 XBRL DEFINITION FILE uncy-20240930_def.xml EX-101.DEF 325699
10 XBRL LABEL FILE uncy-20240930_lab.xml EX-101.LAB 582112
11 XBRL PRESENTATION FILE uncy-20240930_pre.xml EX-101.PRE 344250
79 EXTRACTED XBRL INSTANCE DOCUMENT ea0220114-10q_unicycive_htm.xml XML 829671
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40582 | Film No.: 241451142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)